Yohimbine Promotes Cardiac Ne Release And Prevents Lps-Induced Cardiac Dysfunction Via Blockade Of Presynaptic Alpha(2a)-Adrenergic Receptor

Yiyang Wang,Xiaohui Yu,Faqiang Wang,Yuan Wang,Yanping Wang,Hongmei Li,Xiuxiu Lv,Daxiang Lu,Huadong Wang

DOI: https://doi.org/10.1371/journal.pone.0063622

IF: 3.7

2013-01-01

PLoS ONE

Abstract:Myocardial depression is an important contributor to mortality in sepsis. We have recently demonstrated that alpha 2-adrenoceptor (AR) antagonist, yohimbine (YHB), attenuates lipopolysaccharide (LPS)-induced myocardial depression. However, the mechanisms for this action of YHB are unclear. Here, we demonstrated that YHB decreased nitric oxide (NO) and tumor necrosis factor-alpha (TNF-alpha) levels in the myocardium and plasma, attenuated cardiac and hepatic dysfunction, but not kidney and lung injuries in endotoxemic mice. Immunohistochemical analysis revealed that cardiac alpha(2A)-AR was mostly located in sympathetic nerve presynaptic membrane; YHB decreased cardiac alpha(2A)-AR level and promoted cardiac norepinephrine (NE) release in endotoxemic mice. Reserpine that exhausted cardiac NE without markedly decreasing plasma NE level abrogated the inhibitory effects of YHB on cardiac TNF-alpha and iNOS expression as well as cardiac dysfunction, but not the suppressive effects of YHB on plasma TNF-alpha and NO elevation in LPS-challenged mice. Furthermore, both reserpine and YHB significantly inhibited LPS-induced myocardial apoptosis. alpha(1)-AR, beta(2)-AR, but not beta(1)-AR antagonists reversed the inhibitory effect of YHB on LPS-stimulated myocardial apoptosis. However, beta(1)-AR antagonist attenuated LPS-caused cardiomyocyte apoptosis, partly abolished the protective effect of YHB on the left ventricular ejection fraction in endotoxemic mice. Altogether, these findings indicate that YHB attenuates LPS-induced cardiac dysfunction, at least in part, through blocking presynaptic alpha(2A)-AR and thus increasing cardiac NE release. YHB-elevated cardiac NE improves cardiac function via suppressing cardiac iNOS and TNF-alpha expression, activating beta(1)-AR and inhibiting cardiomyocyte apoptosis through alpha(1)- and beta(2)-AR in endotoxemic mice. However, cardiac beta(1)-AR activation promotes LPS-induced cardiomyocyte apoptosis.